You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Laurie H. Glimcher

President & Chief Executive Officer at Dana-Farber Cancer Institute, Inc.
Relationship Science aggregates deep and verified information on over 6 million influential decision makers and the over 1.5 million organizations with which they are associated. From this data, we create a "business social graph" that highlights who knows whom. Here are Laurie H. Glimcher's strongest connections.

People Most Closely Connected to Laurie H. Glimcher

Click the names below to expand relationship details.
Craig B. Thompson
President & Chief Executive Officer at Memorial Sloan Kettering Cancer Center
Marc Tessier-Lavigne
President at Stanford University
Paul A. Marks
Laboratory Head of Cell Biology at Memorial Sloan Kettering Cancer Center
Charles L. Sawyers
Chairman, Human Oncology & Pathogenesis Program at Memorial Sloan Kettering Cancer Center
Richard Axel
Founder at Kallyope, Inc.
R Sanders Williams
Professor of Medicine at UCSF School of Medicine
Christopher T. Walsh
Consulting Professor, Department of Chemistry at Stanford University
Juan Cubillos-Ruiz
Scientific Co-Founder at Quentis Therapeutics, Inc.
David M. Livingston
Faculty Member at Harvard University - Harvard Medical School
José Baselga
Chief Medical Officer at Memorial Sloan Kettering Cancer Center
Drew M. Pardoll
Founder at Jounce Therapeutics, Inc.
Ira Mellman
Vice President, Cancer Immunology at Genentech, Inc.
Carl F. Nathan
Professor of Microbiology & Immunology at Cornell University - Weill Cornell Medical College
David Scheinberg
Chair, Experimental Therapeutics Center at Memorial Sloan Kettering Cancer Center
Jedd Wolchok
Lloyd J. Old Chair for Clinical Investigation at Memorial Sloan Kettering Cancer Center
Emil Unanue
Paul & Ellen Lacy Professor of Pathology at Washington University in St.Louis - School of Medicine
Thomas J. Lynch, Jr.
Executive Vice President & Chief Scientific Officer at Bristol-Myers Squibb Company
Andrew Dannenberg
Co-Director, Cancer Prevention Program at New York Presbyterian Hospital
8,182 more connections are available with a RelSci Professional subscription.